| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Epoxomicin |
|---|
| Description | Originally isolated from Actinomycetes strain based on its potent in vivo antitumor activity, Epoxomicin is a potent, cell-permeable, selective and irreversible proteasome inhibitor. More potent inhibitor of the chymotrypsin-like activity of the proteasome than Lactacystin (Cat. No. 1709-100). Blocks also trypsin-like and PGPH activities of the proteasome. MW: 554.7. Purity ≥95% by HPLC |
|---|
| Size | 50 μg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-?acetyl-?N-?methyl-?L-?isoleucyl-?L-?isoleucyl-?N-?[(1S)-?3-?methyl-? 1-?[[(2R)-?2-?methyloxiranyl]carbonyl]butyl]-?L-?threoninamide; BU-4061T |
|---|
| Gene, Accession, CAS # | CAS: 134381-21-8 |
|---|
| Catalog # | 2190-50 |
|---|
| Price | |
|---|
| Order / More Info | Epoxomicin from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|